SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium
Open accessThe DOI matches its Crossref record; 80 of the 83 references it cites were found in a registry or an index; none of the 36 sources its claims cite is checked for support yet.
Abstract
Various reports indicate an association between COVID-19 and anosmia, suggesting an infection of the olfactory sensory epithelium, and thus a possible direct virus access to the brain. To test this hypothesis, we generated RNA-seq libraries from human olfactory neuroepithelia, in which we found substantial expression of the genes coding for the virus receptor angiotensin-converting enzyme-2 (ACE2), and for the virus internalization enhancer TMPRSS2. We analyzed a human olfactory single-cell RNA-seq dataset and determined that sustentacular cells, which maintain the integrity of olfactory sensory neurons, express ACE2 and TMPRSS2 . We then observed that the ACE2 protein was highly expressed in a subset of sustentacular cells in human and mouse olfactory tissues. Finally, we found ACE2 transcripts in specific brain cell types, both in mice and humans. Sustentacular cells thus represent a potential entry door for SARS-CoV-2 in a neuronal sensory system that is in direct connection with the brain.
Overview
CoChat Summary
TL;DR
Human olfactory neuroepithelium expresses SARS-CoV-2 entry genes, with ACE2 and TMPRSS2 enriched in sustentacular cells rather than olfactory sensory neurons. ACE2 transcripts/protein were also found in specific brain cell types, suggesting potential routes for infection and anosmia.
Key findings
- Bulk RNA-seq of human nasal biopsies found mean ACE2 and TMPRSS2 expression in olfactory sensory neuroepithelium (4.6 and 76.1 TPM, respectively) and respiratory epithelium (7.1 and 63.7 TPM, respectively), indicating entry-gene expression in both tissues.
- In a public single-cell RNA-seq dataset of 28,726 cells from four adult patients, sustentacular cells and respiratory ciliated cells showed the highest coexpression of ACE2 and TMPRSS2; olfactory sensory neurons showed little or no expression. ACE2-positive sustentacular cells numbered 71 versus 3,011 ACE2-negative, and ACE2-positive respiratory ciliated cells numbered 19 versus 567 ACE2-negative.
- Immunohistochemistry confirmed ACE2 protein in a subset of sustentacular cells in mouse and human olfactory tissues; in mouse, ACE2 labeling was apical and restricted to dorsal, not ventral, olfactory epithelium. TMPRSS2 labeling was observed in many nasal epithelium constituents.
- In mouse brain datasets, Ace2 was limited mainly to pericytes/mural cells and not neurons; in human brain datasets, ACE2 was found in non-neuronal and neuronal types including astrocytes, oligodendrocytes, Purkinje neurons, and cortical layer 5 neurons, with some coexpressing TMPRSS2.
Methods
- Bulk RNA-seq libraries were generated from human olfactory and respiratory nasal biopsies collected via nasal endoscopic surgery from four adult patients, followed by differential expression analysis.
- Public single-cell RNA-seq data from human olfactory/nasal tissue (Durante et al., 2020; 28,726 cells, 26 clusters) were reanalyzed for ACE2, TMPRSS2, ERMN, and GSTA2 expression and coexpression.
- Immunohistochemistry was performed on mouse and human olfactory tissues and mouse olfactory bulb using anti-ACE2 and anti-TMPRSS2 antibodies with neuronal/sustentacular markers (TUJ1, OMP, ERMN); olfactory epithelium from two deceased SARS-CoV-2-infected individuals was also examined.
Limitations
- Stated: the olfactory sensory epithelium from two deceased SARS-CoV-2-infected individuals was highly damaged and largely detached from the basal lamina, hindering identification of viral particles in sustentacular cells; whether the damage was caused by the virus could not be determined from the few samples analyzed.
- Evident from the text: sample sizes are small (four adult patients for biopsies; two deceased infected individuals), and brain expression conclusions rely partly on public datasets with possible differences in sequencing depth, protocol, mRNA half-lives, or cell-type selection.
- Evident from the text: the study does not demonstrate functional SARS-CoV-2 infection of sustentacular cells or establish causality for anosmia; the authors note that inflammation or infection of other non-neuronal cell types cannot be excluded.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 0 Not valid · 24 Not checked · 52 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Congruently with its pervasiveness in the single-cell transcriptomes, TMPRSS2 labeling was observed in many constituents of the nasal epithelium (Figures 4H, S4F, and S4G).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > ACE2 and TMPRSS2 Protein Expression in the Olfactory Neuroepithelium
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the first collection, published by Zeisel et al. (2018), which includes non-neuronal cells, we found a very limited number of cell types that expressed Ace2 (Figure 5A).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > SARS-CoV-2 Receptor Expression in the Brain
What the sources say
- Not checked yetcites Zeisel et al. (2018)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we generated RNA-seq libraries from human olfactory neuroepithelia, in which we found substantial expression of the genes coding for the virus receptor angiotensin-converting enzyme-2 (ACE2) and for the virus internalization enhancer TMPRSS2.”
- Also stated in: § Expression of ACE2 and TMPRSS2 Human Sustentacular and Respiratory Ciliated Cells · hedged
“We found a mean of 4.6 and 76.1 TPMs in the sensory neuroepithelium samples for ACE2 and TMPRSS2, respectively (Figures 1F and 1G), indicating the presence in this tissue of cells that may express both genes, or of a mix of cells that express either TMPRSS2 or ACE2.”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Abstract
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Expression of ACE2 and TMPRSS2 Human Sustentacular and Respiratory Ciliated Cells · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the olfactory cavity, a strong and defined labeling was observed in the respiratory epithelium in the nasal cavity and nasopharyngeal duct (Figures S3A–S3H), and in a subset of sustentacular cells lining the nasal cavity (Figures 3C–3G and S3B).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > ACE2 and TMPRSS2 Protein Expression in the Olfactory Neuroepithelium
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Olfactory sensory neurons showed little or no expression of TMPRSS2 and ACE2, respectively (Figure 2C).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > Expression of ACE2 and TMPRSS2 Human Sustentacular and Respiratory Ciliated Cells
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
45 more claims
Create a free account to see all 76 claims and to verify the 36 references still open.
- It may state two separate claims as one. 15
- Probably not a substantial claim. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ACE2 expression has been reported for many tissues/organs including the lung (ie, lung type II alveolar cells/AT2, bronchial epithelial cells), brain, kidney, small intestine, colon, and heart.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Studies reported that human olfactory sustentacular cells express both ACE2 and TMPRSS2 virus receptors [33].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [33]
In the citing paper
“Although current literature data reports that human olfactory sensory neurons do not express these proteins, they express CD147 that could allow SARS-CoV-2 neuroinvasion (Fig. 1) [33, 34].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [33]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · cited 3×
“2 Infection by this RNA virus is associated with a severe respiratory syndrome called COVID-19, and is characterized by a significant mortality rate 1, 3, 4 .”
BackgroundHoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Research works printed but not linked: 2
- Nampoothiri S. Sauve F. Ternier G. Fernandois D. Coelho C. Imbernon M. Deligia E. Perbet R. Florent V. Baroncini M. The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis bioRxiv 2020 10.1101/2020.06.08.139329 · DOI
- Fodoulian L. Tuberosa J. Rossier D. Boillat M. Kan C. Pauli V. Egervari K. Lobrinus J.A. Landis B.N. Carleton A. SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium bioRxiv 2020 10.1101/2020.03.31.013268 PMC7685946 33251489
Cited by
Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., Quentric, P., Fadlallah, J., Devilliers, H., Ghillani, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2223 · Cited by 1,037
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2065 · Cited by 923
Zhu, Z., Lian, X., Su, X., Wu, W., Marraro, G. A., & Zeng, Y. (2020) · Respiratory Research · doi:10.1186/s12931-020-01479-w · Cited by 614
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
Parma, V., Ohla, K., Veldhuizen, M. G., Niv, M. Y., Kelly, C. E., Bakke, A. J., Cooper, K. W., Bouysset, C., Pirastu, N., Dibattista, M., et al. (2020) · Chemical Senses · doi:10.1093/chemse/bjaa041 · Cited by 508
Lifting the mask on neurological manifestations of COVID-19
Pezzini, A., & Padovani, A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0398-3 · Cited by 447
Bilinska, K., Jakubowska, P., Von Bartheld, C. S., & Butowt, R. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00210 · Cited by 431
Khan, M., Yoo, S.-J., Clijsters, M., Backaert, W., Vanstapel, A., Speleman, K., Lietaer, C., Choi, S., Hether, T. D., Marcelis, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.10.027 · Cited by 370
Harapan, B. N., & Yoo, H. J. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10406-y · Cited by 359
Neurological Involvement in COVID-19 and Potential Mechanisms: A Review
Aghagoli, G., Gallo Marin, B., Katchur, N. J., Chaves-Sell, F., Asaad, W. F., & Murphy, S. A. (2021) · Neurocritical Care · doi:10.1007/s12028-020-01049-4 · Cited by 357
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Butowt, R., & von Bartheld, C. S. (2021) · The Neuroscientist · doi:10.1177/1073858420956905 · Cited by 345
COVID-19 and the Chemical Senses: Supporting Players Take Center Stage
Cooper, K. W., Brann, D. H., Farruggia, M. C., Bhutani, S., Pellegrino, R., Tsukahara, T., Weinreb, C., Joseph, P. V., Larson, E. D., Parma, V., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.032 · Cited by 340
Bryche, B., St Albin, A., Murri, S., Lacôte, S., Pulido, C., Ar Gouilh, M., Lesellier, S., Servat, A., Wasniewski, M., Picard-Meyer, E., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.06.032 · Cited by 307
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19
Ahn, J. H., Kim, J., Hong, S. P., Choi, S. Y., Yang, M. J., Ju, Y. S., Kim, Y. T., Kim, H. M., Rahman, M. T., Chung, M. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148517 · Cited by 288
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 281
Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview
Behzad, S., Aghaghazvini, L., Radmard, A. R., & Gholamrezanezhad, A. (2020) · Clinical Imaging · doi:10.1016/j.clinimag.2020.05.013 · Cited by 277
Steardo, L., Steardo, L., & Verkhratsky, A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00949-5 · Cited by 219
The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
Bauer, L., Laksono, B. M., de Vrij, F. M. S., Kushner, S. A., Harschnitz, O., & van Riel, D. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.02.006 · Cited by 217
Cheemarla, N. R., Watkins, T. A., Mihaylova, V. T., Wang, B., Zhao, D., Wang, G., Landry, M. L., & Foxman, E. F. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20210583 · Cited by 213
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Trypsteen, W., Van Cleemput, J., Snippenberg, W. V., Gerlo, S., & Vandekerckhove, L. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009037 · Cited by 199
Hornuss, D., Lange, B., Schröter, N., Rieg, S., Kern, W. V., & Wagner, D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.05.017 · Cited by 196
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Climate change, environment pollution, COVID-19 pandemic and mental health
Marazziti, D., Cianconi, P., Mucci, F., Foresi Crowther, L., Chiarantini, I., & Della Vecchia, A. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145182 · Cited by 192
Borsetto, D., Hopkins, C. L., Phillips, V., Obholzer, R., Tirelli, G., Polesel, J., Calvanese, L., & Boscolo‐Rizzo, P. (2020) · Rhinology Journal · doi:10.4193/rhin20.185 · Cited by 175
Wang, L., Shen, Y., Li, M., Chuang, H., Ye, Y., Zhao, H., & Wang, H. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09974-2 · Cited by 172
Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI
Aragão, M. F. V. V., Leal, M. C., Cartaxo Filho, O. Q., Fonseca, T. M., & Valença, M. M. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6675 · Cited by 169
Jha, N. K., Ojha, S. K., Jha, S. K., Dureja, H., Singh, S. K., Shukla, S. D., Chellappan, D. K., Gupta, G., Bhardwaj, S., Kumar, N., et al. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01767-6 · Cited by 165
COVID-19, SARS and MERS: A neurological perspective
Ng Kee Kwong, K. C., Mehta, P. R., Shukla, G., & Mehta, A. R. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.04.124 · Cited by 156
Neuromechanisms of SARS-CoV-2: A Review
DosSantos, M. F., Devalle, S., Aran, V., Capra, D., Roque, N. R., Coelho-Aguiar, J. D. M., Spohr, T. C. L. D. S. E., Subilhaga, J. G., Pereira, C. M., D'Andrea Meira, I., et al. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.00037 · Cited by 155
Anosmia in COVID-19: Mechanisms and Significance
Han, A. Y., Mukdad, L. A., Long, J. L., & López, I. A. (2020) · Chemical Senses · doi:10.1093/chemse/bjaa040 · Cited by 149
Mutiawati, E., Fahriani, M., Mamada, S. S., Fajar, J. K., Frediansyah, A., Maliga, H. A., Ilmawan, M., Emran, T. B., Ophinni, Y., Ichsan, I., et al. (2021) · F1000Research · doi:10.12688/f1000research.28393.1 · Cited by 147
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145
“Studies reported that human olfactory sustentacular cells express both ACE2 and TMPRSS2 virus receptors [33].”
BackgroundJoshee, S. R., Vatti, N., & Chang, C. C.-C. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.12.017 · Cited by 142
Biering, S. B., Sarnik, S. A., Wang, E., Zengel, J. R., Leist, S. R., Schäfer, A., Sathyan, V., Hawkins, P., Okuda, K., Tau, C., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01131-x · Cited by 142
SARS-CoV-2 Infects Neurons and Induces Neuroinflammation in a Non-Human Primate Model of COVID-19
Beckman, D., Bonillas, A. C., Diniz, G. B., Ott, S. P., Roh, J. W., Elizaldi, S. R., Schmidt, B., Sammak, R. L., Rompay, K. K. A. V., Iyer, S. S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111573 · Cited by 141
Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19
Boscolo‐Rizzo, P., Menegaldo, A., Fabbris, C., Spinato, G., Borsetto, D., Vaira, L. A., Calvanese, L., Pettorelli, A., Sonego, M., Frezza, D., et al. (2021) · Chemical Senses · doi:10.1093/chemse/bjab006 · Cited by 137
Neuropathology of COVID-19 (neuro-COVID): clinicopathological update
Lou, J. J., Movassaghi, M., Gordy, D. E., Olson, M. G., Zhang, T., Khurana, M. S., Chen, Z., Perez-Rosendahl, M. A., Thammachantha, S., Singer, E. J., et al. (2021) · Free Neuropathology · doi:10.17879/freeneuropathology-2021-2993 · Cited by 135
Butowt, R., Meunier, N., Bryche, B., & von Bartheld, C. S. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02314-2 · Cited by 132
Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health
Doty, R. L. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.06.005 · Cited by 127
Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments
Najafloo, R., Majidi, J., Asghari, A., Aleemardani, M., Kamrava, S. K., Simorgh, S., Seifalian, A., Bagher, Z., & Seifalian, A. M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00477 · Cited by 118
The Ocular Surface and the Coronavirus Disease 2019: Does a Dual ‘Ocular Route’ Exist?
Napoli, P. E., Nioi, M., d’Aloja, E., & Fossarello, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051269 · Cited by 115
Sauvé, F., Nampoothiri, S. S., Clarke, S. A., Fernandois, D., Coêlho, C. F. F., Dewisme, J., Mills, E., Ternier, G., Cotellessa, L., Iglesias, C., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104784 · Cited by 113
Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism
Bilińska, K., & Butowt, R. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00406 · Cited by 110
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐19
Maiese, A., Manetti, A. C., Bosetti, C., Del Duca, F., La Russa, R., Frati, P., Di Paolo, M., Turillazzi, E., & Fineschi, V. (2021) · Brain Pathology · doi:10.1111/bpa.13013 · Cited by 109
Vonck, K. E. J., Garrez, I., Herdt, V. D., Hemelsoet, D., Laureys, G., Raedt, R., & Boon, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14329 · Cited by 108
Vargas, G., Geraldo, L. H., Salomão, N. G., Paes, M. V., Lima, F. R. S., & Gomes, F. C. A. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100127 · Cited by 106
Fumagalli, V., Ravà, M., Marotta, D., Lucia, P. D., Laura, C., Sala, E., Grillo, M., Bono, E. B., Giustini, L., Perucchini, C., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl9929 · Cited by 103
Yao, Y., Wang, H., & Liu, Z. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13746 · Cited by 102
SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury
Fenrich, M., Mrdenovic, S., Balog, M., Tomic, S., Zjalic, M., Roncevic, A., Mandic, D., Debeljak, Z., & Heffer, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00229 · Cited by 95
Neurological Complications of COVID-19: Underlying Mechanisms and Management
Shehata, G. A., Lord, K. C., Grudzinski, M. C., Elsayed, M., Abdelnaby, R., & Elshabrawy, H. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084081 · Cited by 87
Case Series of Headache Characteristics in COVID‐19: Headache Can Be an Isolated Symptom
Toptan, T., Aktan, Ç., Başarı, A., & Bolay, H. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13940 · Cited by 85
COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology
Meunier, N., Briand, L. V., Jacquin, A., Brondel, L., & Pénicaud, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.625110 · Cited by 84
Johansson, A., Mohamed, M. S., Moulin, T. C., & Schiöth, H. B. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577658 · Cited by 84
ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations
Hernández, V. S., Zetter, M. A., Guerra, E. C., Hernández‐Araiza, I., Karuzin, N., Hernández‐Pérez, O. R., Eiden, L. E., & Zhang, L. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113837 · Cited by 82
Long COVID Neuropsychological Deficits after Severe, Moderate, or Mild Infection
Voruz, P., Allali, G., Benzakour, L., Nuber‐Champier, A., Thomasson, M., de Alcântara, I. J., Pierce, J. E., Lalive, P. H., Lövblad, K., Braillard, O., et al. (2022) · Clinical and Translational Neuroscience · doi:10.3390/ctn6020009 · Cited by 79
Self-citationSARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways
Verma, A. K., Zheng, J. H., Meyerholz, D. K., & Perlman, S. M. (2022) · JCI Insight · doi:10.1172/jci.insight.160277 · Cited by 79
Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review
Orrù, G., Conversano, C., Malloggi, E., Francesconi, F., Ciacchini, R., & Gemignani, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186688 · Cited by 79
Evolution of Olfactory Disorders in COVID ‐19 Patients
Gorzkowski, V., Bevilacqua, S., Charmillon, A., Jankowski, R., Gallet, P., Rumeau, C., & Nguyen, D. T. (2020) · The Laryngoscope · doi:10.1002/lary.28957 · Cited by 78
Neurotropic Viruses, Astrocytes, and COVID-19
Verdev, P. T., Potokar, M., Kolenc, M., Korva, M., Avšič‐Županc, T., Zorec, R., & Jorgačevski, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662578 · Cited by 77
Viral infection and smell loss: The case of COVID‐19
Glezer, I., Bruni‐Cardoso, A., Schechtman, D., & Malnic, B. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15197 · Cited by 76
Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia
小山, 幸., Kondo, K., Ueha, R., Kashiwadani, H., & Heinbockel, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168912 · Cited by 72
Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
Khani, E., Khiali, S., Beheshtirouy, S., & Entezari‐Maleki, T. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174582 · Cited by 72
Boscolo‐Rizzo, P., Borsetto, D., Spinato, G., Fabbris, C., Menegaldo, A., Gaudioso, P., Nicolai, P., Tirelli, G., Mosto, M. C. D., Rigoli, R., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-06066-9 · Cited by 70
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
Vidal, E., López-Figueroa, C., Rodon, J., Pérez, M., Brustolin, M., Cantero, G., Guallar, V., Izquierdo‐Useros, N., Carrillo, J., Blanco, J., et al. (2021) · Veterinary Pathology · doi:10.1177/03009858211066841 · Cited by 69
Neurological manifestations in COVID-19: A narrative review
Rahman, A., Niloofa, R., Zoysa, I. D., Cooray, A., Kariyawasam, J., & Seneviratne, S. L. (2020) · SAGE Open Medicine · doi:10.1177/2050312120957925 · Cited by 67
Mechanisms of SARS-CoV-2-associated anosmia
Tsukahara, T., Brann, D. H., & Datta, S. R. (2023) · Physiological Reviews · doi:10.1152/physrev.00012.2023 · Cited by 66
Lechner, M., Chandrasekharan, D. P., Jumani, K., Liu, J., Gane, S. B., Lund, V. J., Philpott, C. M., & Jayaraj, S. M. (2020) · Rhinology Journal · doi:10.4193/rhin20.189 · Cited by 65
Neta, F. I., Fernandes, A. C. L., Vale, A. J. M., Pinheiro, F. I., Cobucci, R. N., de Azevedo, E. P., & Gúzen, F. P. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100035 · Cited by 64
SARS-CoV-2 on the ocular surface: is it truly a novel transmission route?
Chen, X., Yu, H., Mei, T., Chen, B., Chen, L., Li, S., Zhang, X., & Sun, X. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-316263 · Cited by 63
A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View
Zangbar, H. S., Gorji, A., & Ghadiri, T. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02149-0 · Cited by 63
Borah, P., Deb, P. K., Chandrasekaran, B., Goyal, M., Bansal, M., Hussain, S., Shinu, P., Venugopala, K. N., Al‐Shar’i, N. A., Deka, S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.627723 · Cited by 57
Rodriguez, S., Cao, L., Rickenbacher, G. T., Benz, E. G., Magdamo, C., Gomez, L. A. R., Holbrook, E. H., Albers, A. D., Gallagher, R., Westover, M. B., et al. (2020) · medRxiv · doi:10.1101/2020.06.14.20131128 · Cited by 55
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
Aliabadi, H. A. M., Eivazzadeh‐Keihan, R., Parikhani, A. B., Mehraban, S. F., Maleki, A. R., Fereshteh, S., Bazaz, M., Zolriasatein, A., Bozorgnia, B., Rahmati, S., et al. (2022) · MedComm · doi:10.1002/mco2.115 · Cited by 52
Prolonged and extended impacts of SARS-CoV-2 on the olfactory neurocircuit
Kishimoto‐Urata, M., Urata, S., Kagoya, R., Imamura, F., Nagayama, S., Reyna, R. A., Maruyama, J., Yamasoba, T., Kondo, K., Hasegawa‐Ishii, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09731-7 · Cited by 50
Quantitative Assessment of Olfactory Dysfunction Accurately Detects Asymptomatic COVID-19 Carriers
Bhattacharjee, A. S., Joshi, S. V., Naik, S., Sangle, S. A., & Abraham, N. M. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100575 · Cited by 49
Bourgon, C., Deliot, A. S.-A., Grard, O., da Costa, B. R., Domain, R., Korkmaz, B., Klonjkowski, B., Poder, S. L., & Meunier, N. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04643-1 · Cited by 45
Hasegawa, Y., Ma, M., Sawa, A., Lane, A. P., & Kamiya, A. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02081-y · Cited by 45
Liang, F., & Wang, D. Y. (2021) · Viruses · doi:10.3390/v13112225 · Cited by 43
Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights
Schober, M. E., Pavia, A. T., & Bohnsack, J. F. (2021) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002774 · Cited by 40
Revealing the mystery of persistent smell loss in long COVID patients
Park, J. W., Wang, X., & Xu, R. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73485 · Cited by 39
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases
Klein, R. S. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001049 · Cited by 38
Olfactory immune response to SARS-CoV-2
Wellford, S. A., & Moseman, E. A. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01119-5 · Cited by 37
Altered taste in patients with COVID‐19: The potential role of salivary glands
Pedrosa, M. D. S., Sipert, C. R., & Nogueira, F. N. (2020) · Oral Diseases · doi:10.1111/odi.13496 · Cited by 37
Complications and Pathophysiology of COVID-19 in the Nervous System
Yu, H., Sun, T., & Feng, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.573421 · Cited by 37
Stewart, R., Yan, K., Ellis, S. A., Bishop, C. R., Dumenil, T. D., Tang, B., Nguyen, W., Larcher, T., Parry, R. H., Sng, J. D. J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1320856 · Cited by 36
ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19
Pietzner, M., Chua, R. L., Wheeler, E., Jechow, K., Willett, J., Radbruch, H., Trump, S., Heidecker, B., Zeberg, H., Heppner, F. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31999-6 · Cited by 33
Pathogenesis of Olfactory Disorders in COVID-19
Ziuzia-Januszewska, L., & Januszewski, M. (2022) · Brain Sciences · doi:10.3390/brainsci12040449 · Cited by 33
Neurochemical biomarkers to study CNS effects of COVID‐19: A narrative review and synthesis
Edén, A., Simrén, J., Price, R. W., Zetterberg, H., & Gisslén, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15459 · Cited by 32
Vakili, K. G., Fathi, M., Yaghoobpoor, S., Sayehmiri, F., Nazerian, Y., Nazerian, A., Mohamadkhani, A., Khodabakhsh, P., Réus, G. Z., Hajibeygi, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.983089 · Cited by 32
The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations
Barrantes, F. J. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100251 · Cited by 32
Valyaeva, A. A., Zharikova, A. A., & Sheval, E. V. (2022) · Cell Biology International · doi:10.1002/cbin.11928 · Cited by 32
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
Meacci, E., Garcia‐Gil, M., & Pierucci, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186773 · Cited by 32
Castrejón-Jiménez, N. S., García‐Pérez, B. E., Rodríguez, N. E. R., Vega-Sánchez, V., Juárez, V. M. M., & Hernández-González, J. C. (2022) · Biosensors · doi:10.3390/bios12090728 · Cited by 31
Dysautonomia and Implications for Anosmia in Long COVID-19 Disease
Vallée, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235514 · Cited by 31
Zhao, Y., Liu, Y., Yi, F., Zhang, J., Xu, Z., Liu, Y., & Tao, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107406 · Cited by 31
Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
Alsafi, R. (2022) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2022/1156273 · Cited by 30
SARS-CoV-2 (COVID-19) as a possible risk factor for neurodevelopmental disorders
Dubey, H., Sharma, R. K., Krishnan, S., & Knickmeyer, R. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1021721 · Cited by 29
Mechanisms of COVID‐19‐associated olfactory dysfunction
Chang, K., Zaikos, T. D., Kilner‐Pontone, N., & Ho, C. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12960 · Cited by 29
Anosmia y enfermedad por Coronavirus 2019 (COVID-19): ¿Qué debemos saber?
Sepúlveda, V., Sofía Waissbluth, A., & Claudia González, G. (2020) · Revista de otorrinolaringología y cirugía de cabeza y cuello · doi:10.4067/s0718-48162020000200247 · Cited by 29
Metadata
- Authors
- Fodoulian, L., Tuberosa, J., Rossier, D., Boillat, M., Kan, C., Pauli, V., Egervari, K., Lobrinus, J. A., Landis, B. N., Carleton, A., & Rodriguez, I.
- Affiliations
- University of Geneva (CH)
- University Hospital of Geneva (CH)
- Corresponding author
- Carleton, Alan
- ORCID
- Venue
- iScience
- Publisher
- openRxiv
- Published
- 2020-04-02
- Volume
- 23
- Issue
- 12
- Pages
- 101839-101839
- ISSN
- 2589-0042 (ISSN-L)
- PMC
- PMC7685946
- OpenAlex
- W3107452553
- Cited by
- 286
- References
- 83
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 29 · 2023: 46 · 2022: 68 · 2021: 68 · 2020: 60
- FWCI
- 21.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.biorxiv.org/about/FAQ#license (vor)
- Locations
- iScience (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by-nd)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (172878, 189153)
- Université de Genève (31003A_172878, 310030_189153)
- Institute of Genetics and Genomics of Geneva
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, olfactory epithelium, ACE2, TMPRSS2, sustentacular cells, olfactory sensory neurons, anosmia, olfactory bulb, viral entry, single-cell RNA sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.